These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease. Singh A; Gosai F; Siddiqui MT; Gupta M; Lopez R; Lawitz E; Poordad F; Carey W; McCullough A; Alkhouri N J Clin Gastroenterol; 2020; 54(10):891-897. PubMed ID: 32168133 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ; Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027 [TBL] [Abstract][Full Text] [Related]
8. Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease. Petta S; Wai-Sun Wong V; Bugianesi E; Fracanzani AL; Cammà C; Hiriart JB; Lai-Hung Wong G; Vergniol J; Wing-Hung Chan A; Giannetti A; Merrouche W; Lik-Yuen Chan H; Le-Bail B; Lombardi R; Guastella S; Craxì A; de Ledinghen V Am J Gastroenterol; 2019 Jun; 114(6):916-928. PubMed ID: 31169533 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Six Noninvasive Methods for the Detection of Fibrosis in Chinese Patients with Obesity and Nonalcoholic Fatty Liver Disease. Chen G; Yang JC; Zhang GX; Cheng Z; Du X Obes Surg; 2022 Nov; 32(11):3619-3626. PubMed ID: 36070119 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease. Marella HK; Reddy YK; Jiang Y; Ganguli S; Podila PSB; Snell PD; Kovalic AJ; Cholankeril G; Singal AK; Nair S; Maliakkal B; Satapathy SK Clin Transl Gastroenterol; 2020 Apr; 11(4):e00165. PubMed ID: 32352687 [TBL] [Abstract][Full Text] [Related]
11. Performance of Noninvasive Liver Fibrosis Scores in the Morbid Obese Patient, Same Scores but Different Thresholds. Meneses D; Olveira A; Corripio R; Del Carmen Méndez M; Romero M; Calvo-Viñuelas I; Herranz L; Vicent D; de-Cos-Blanco AI Obes Surg; 2020 Jul; 30(7):2538-2546. PubMed ID: 32157523 [TBL] [Abstract][Full Text] [Related]
12. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086 [TBL] [Abstract][Full Text] [Related]
13. Step layered combination of noninvasive fibrosis models improves diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease. Yang M; Jiang L; Wang Y; Li X; Zou Z; Han T; Nan Y; Lu F; Zhao J J Gastrointestin Liver Dis; 2019 Sep; 28(3):289-296. PubMed ID: 31517325 [TBL] [Abstract][Full Text] [Related]
15. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease. Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410 [TBL] [Abstract][Full Text] [Related]
16. Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease. Huang C; Seah JJ; Tan CK; Kam JW; Tan J; Teo EK; Kwek A; Wong YJ; Tan M; Ang TL; Kumar R Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101528. PubMed ID: 33268036 [TBL] [Abstract][Full Text] [Related]
17. Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease. Xun YH; Fan JG; Zang GQ; Liu H; Jiang YM; Xiang J; Huang Q; Shi JP J Dig Dis; 2012 Nov; 13(11):588-95. PubMed ID: 23107446 [TBL] [Abstract][Full Text] [Related]
18. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. Wu YL; Kumar R; Wang MF; Singh M; Huang JF; Zhu YY; Lin S World J Gastroenterol; 2021 Sep; 27(34):5753-5763. PubMed ID: 34629799 [TBL] [Abstract][Full Text] [Related]
19. The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. Petta S; Vanni E; Bugianesi E; Di Marco V; Cammà C; Cabibi D; Mezzabotta L; Craxì A Liver Int; 2015 May; 35(5):1566-73. PubMed ID: 24798049 [TBL] [Abstract][Full Text] [Related]